Publications (22) JOSÉ ANTONIO ROMERO GARRIDO publications

2024

  1. Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast

    Journal of Oncology Pharmacy Practice

2023

  1. Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105

  2. Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies

    Expert Review of Hematology, Vol. 16, Núm. 3, pp. 213-226

2022

  1. Iniciativas para la mejora del manejo de los pacientes con coagulopatías congénitas por parte de farmacia hospitalaria

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 109-115

  2. Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs

    BMC Health Services Research, Vol. 22, Núm. 1

2021

  1. Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 5, pp. 268-272

  2. Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E66-E71

2020

  1. Registry of patients with congenital bleeding disorders and COVID-19 in Madrid

    Haemophilia, Vol. 26, Núm. 5, pp. 773-778

2019

  1. Accelerating recovery from acute hemarthrosis in patients with hemophilia: The role of joint aspiration

    Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 111-119

2016

  1. Multimodal blood loss prevention approach including intra-articular tranexamic acid in primary total knee arthroplasty for patients with severe haemophilia A

    Haemophilia

  2. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25 years and its potential association with bleeding episodes

    Thrombosis Research, Vol. 143, pp. 22-27

2015

  1. Pharmacoeconomics of orthopedic surgery in hemophilia

    Joint Surgery in the Adult Patient with Hemophilia (Springer International Publishing), pp. 111-118

2014

  1. Adequacy of clotting factor in haemophilic patients underwent surgery based on analytical parameters and plasmatic clearance

    Atencion Farmaceutica, Vol. 16, Núm. 2, pp. 110-116

  2. Características técnicas de los concentrados de factores de la coagulación: manual para Farmacia Hospitalaria dir.

    Letramédica SCP

  3. Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study

    Thrombosis Research, Vol. 133, Núm. 6, pp. 1045-1051

2013

  1. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Medicina Intensiva, Vol. 37, Núm. 4, pp. 259-283

  2. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 60, Núm. 5

  3. Lipid profile disorder in HIV infected patients treated with lopinavir/ritonavir and its relation with adherence To treatment

    Atencion Farmaceutica, Vol. 15, Núm. 3, pp. 171-177

  4. Study of costs of inhibitor development in patients with severe hemophilia A in Spain

    Pharmacoeconomics - Spanish Research Articles, Vol. 10, Núm. 2, pp. 69-78

  5. Trastuzumab induced cardiotoxicity in patients with HER2+ breast cancer

    Atencion Farmaceutica, Vol. 15, Núm. 4, pp. 261-267